Axsome Therapeutics (AXSM) PT Raised to $217 at Morgan Stanley

April 30, 2026 3:23 PM

Morgan Stanley analyst Sean Laaman raised the price target on Axsome Therapeutics (NASDAQ: AXSM) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found